# Span-C-SBRT for Pancreatic Cancer

> **NCT03505229** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Royal North Shore Hospital** · enrollment: 30 (actual)

## Conditions studied

- High Risk Localised Pancreatic Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy (SBRT)

## Key facts

- **NCT ID:** NCT03505229
- **Lead sponsor:** Royal North Shore Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-12-18
- **Primary completion:** 2028-10-05
- **Final completion:** 2028-10-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03505229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03505229, "Span-C-SBRT for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03505229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*